**Core Concept**
Warfarin is a vitamin K antagonist used as an anticoagulant to prevent thrombosis and thromboembolism. It works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver, including factors II, VII, IX, and X.

**Why the Correct Answer is Right**
Warfarin's mechanism of action involves the inhibition of the enzyme vitamin K epoxide reductase complex 1 (VKORC1), which is necessary for the recycling of vitamin K in the liver. This leads to a decrease in the production of vitamin K-dependent clotting factors, resulting in a decrease in the clotting cascade. Warfarin also affects the synthesis of proteins C and S, which are involved in the regulation of blood clotting.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is a true statement about warfarin. Warfarin is indeed metabolized by the cytochrome P450 enzyme system, specifically by the CYP2C9 isoenzyme.

**Option B:** This option is also a true statement. Warfarin's effect on vitamin K-dependent clotting factors is dose-dependent, and regular monitoring of international normalized ratio (INR) is necessary to ensure therapeutic anticoagulation.

**Option C:** This option is a true statement as well. Warfarin has a narrow therapeutic index, and the risk of bleeding increases when the INR is elevated above the therapeutic range.

**Option D:** This statement is false. Warfarin is actually contraindicated in patients with active bleeding, as it can exacerbate bleeding tendencies.

**Clinical Pearl / High-Yield Fact**
Warfarin's interaction with other medications, such as antibiotics and antifungals, can lead to an increased risk of bleeding due to the induction of CYP2C9 and subsequent increase in warfarin levels.

**Correct Answer: D. Warfarin is actually contraindicated in patients with active bleeding, as it can exacerbate bleeding tendencies.**